Sunshine Biopharma closes $6 million public offering with potential additional $14.4 million from warrant exercises.
Amount Raised
$6 Million
Round Type
Post-IPO Equity
Fort LauderdaleHealthcareHealth CareDescription
Sunshine Biopharma Inc. (NASDAQ: SBFM) closed its public offering on October 9, 2026, securing $6.0 million in upfront gross proceeds. The offering consisted of 10,909,082 Common Units or Pre-Funded Units, each comprising one share of Common Stock or one Pre-Funded Warrant paired with two Series D Warrants. The transaction includes potential for an additional $14.4 million in gross proceeds if Series D warrants are fully exercised, bringing total potential aggregate proceeds to approximately $20.4 million
Quick answer
Sunshine Biopharma raised $6 Million in a Post-IPO Equity round, dated October 9, 2026. Sunshine Biopharma is based in Fort Lauderdale, Florida, United States.
- How much did Sunshine Biopharma raise?
- Sunshine Biopharma raised $6 Million in a Post-IPO Equity round on October 9, 2026.
- What does Sunshine Biopharma do?
- Sunshine Biopharma is a pharmaceutical company that focuses on researching and offering life-saving medicines across various therapeutic areas, including oncology and antivirals.
- Where is Sunshine Biopharma based and how big is it?
- Sunshine Biopharma is based in Fort Lauderdale, Florida, United States. Fundz records about 44 employees.
- Who are the decision-makers at Sunshine Biopharma?
- Fundz holds 1 contact at Sunshine Biopharma, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Sunshine Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Francis Medical raised an undisclosed amount on November 12, 2026.
- XpertDox LLC raised $20M (Series A) on November 11, 2026.
- Actuate Therapeutics raised $10M (Post-IPO Equity) on October 28, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
Who to call at Sunshine Biopharma, and when
A new round usually means Sunshine Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sunshine Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sunshine Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sunshine Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sunshine Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sunshine Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.